BioSpace News Archive

3D printing being used to train young surgeons

Canadian plastic surgeons create hand model to teach fracture pinning

May 22, 2019
·
2 min read
Business

Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement

Halozyme Therapeutics, Inc. announced that argenx has selected a second target under the collaboration and license agreement the companies announced in February 2019.

May 22, 2019
·
4 min read
Deals

Nuevolution AB (publ) Announces its Results for the First Quarter of 2019

Nuevolution AB announces its report for the first quarter of 2019.

May 22, 2019
·
3 min read
Deals

Selvita Reports First Quarter 2019 Financial Results and Provides Corporate Update

Selvita reported first quarter 2019 financial results and provided a corporate update.

May 22, 2019
·
7 min read
Deals

Amgen announces a recommended public cash offer to the shareholders of Nuevolution

Amgen Inc. announces a recommended public cash offer to the shareholders of Nuevolution AB to tender all their shares in Nuevolution to Amgen

May 22, 2019
·
25 min read
Edwards Announces Milestones For Transcatheter Mitral Program

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system.

May 22, 2019
·
4 min read
Global Dental Surgical Equipment Market 2019-2023 | Growing Adoption of 3D Printing Technology by Dental Professionals to Boost Growth | Technavio

The global dental surgical equipment market is expected to post a CAGR close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

May 22, 2019
·
5 min read
Deals

BioInvent Interim Report January 1 - March 31, 2019

BioInvent continued to make good progress in the first quarter, advancing our pipeline and further validating our unique F.I.R.S.TTM platform allowing us to yield actionable leads and develop therapies which have the potential to make a significant difference in the lives of cancer patients.

May 22, 2019
·
4 min read
Deals

Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen

The Board of Directors of Nuevolution unanimously recommends the shareholders of Nuevolution to accept the public offer from Amgen of SEK 32.50 in cash per share

May 22, 2019
·
7 min read
Longas Technologies: Morphoseq™ Novel DNA Sequencing Technology Enables Highly Accurate and Cost Effective Long Read Sequencing on Short Read NGS Platforms

Professor Aaron Darling presented at ‘Sequencing, Finishing and Analysis in the Future’ meeting, May 21 – 23, Santa Fe, NM, USA

May 22, 2019
·
3 min read